Viewing Study NCT00960661

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:40 PM
Ignite Modification Date: 2026-01-31 @ 4:01 PM
Study NCT ID: NCT00960661
Status: COMPLETED
Last Update Posted: 2015-04-07
First Post: 2009-08-17
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diabetes View
None exenatide View
None Byetta View
None insulin lispro View
None Humalog View
None insulin glargine View
None Lantus View
None Amylin View
None Lilly View